no statement of use filed
on 17 Apr 2023
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
913201799
Serial Number
88901543 filed on 05th May 2020
Registration Number
N/A
Correspondent Address
Elsa D. Lemoine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatoryRead More
Pharmaceutical preparations and substances used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma
No 88901543
No Service/Collective Mark
No TM-1489-US-2
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Apr 2023 | ABANDONMENT - NO USE STATEMENT FILED |
17th Apr 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
17th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Sep 2022 | SOU EXTENSION 4 GRANTED |
15th Sep 2022 | SOU EXTENSION 4 FILED |
15th Sep 2022 | TEAS EXTENSION RECEIVED |
17th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Mar 2022 | TEAS EXTENSION RECEIVED |
15th Mar 2022 | SOU EXTENSION 3 GRANTED |
15th Mar 2022 | SOU EXTENSION 3 FILED |